Circon completes merger with Cabot Medical:
This article was originally published in Clinica
Executive Summary
California-based Circon has completed its merger with Cabot Medical (see Clinica No 653, p 1). The merger creates the largest publicly-traded minimally invasive surgery company in urology and gynaecology in the US, says Circon. Cabot, whose stock is no longer being traded on Nasdaq, had revenues of $68 million in fiscal 1994, while Circon had sales of $88.9 million in the year ended December 31st.